A rare and deadly haemorrhagic fever has re-emerged in the Democratic Republic of the Congo, with the World Health Organisation's Africa office confirming an active outbreak of Bundibugyo virus disease on Thursday, 21 May 2026 — the first significant flare-up of the pathogen in years, striking a country still reeling from mpox, cholera, and one of the longest-running Ebola histories on the continent.
Bundibugyo virus disease belongs to the same Filoviridae family as Ebola and Marburg — it is not a household name, but its fatality rate in previous outbreaks has ranged between 25 and 40 percent, and it spreads through direct contact with the blood, organs, or bodily fluids of infected persons. The DRC, home to more than 100 million people, carries the heaviest burden: its eastern provinces — North Kivu, South Kivu, and Ituri — where conflict and displacement have gutted health infrastructure, are home to an estimated 7 million internally displaced persons who face both heightened exposure and near-zero access to isolation facilities.
The virus was first identified in Bundibugyo district in western Uganda in 2007, when an outbreak killed 37 of the 149 confirmed cases. A second outbreak followed in the DRC's Isiro health zone in 2012, killing 36 people. That the pathogen has resurfaced more than a decade later is not a surprise to virologists — filoviruses persist in animal reservoir populations, and the DRC's dense forest ecosystems along the Congo Basin provide exactly the ecological conditions for repeated spillover into human communities.
For Nigeria, the alert is not an abstraction. The country shares active air and trade corridors with the DRC, and the two nations sit within the same WHO Africa regional architecture. Nigeria recorded its first Ebola outbreak in 2014 — also a filovirus — and contained it largely because the Nigeria Centre for Disease Control mobilised quickly at Lagos ports of entry and Lagos Island General Hospital. That institutional memory exists, but Nigeria's 774 local government areas include dozens of land border crossings in Cross River, Borno, and Sokoto states that remain chronically under-resourced for disease surveillance.
WHO Africa, in its disease outbreak notification issued Thursday morning, confirmed the outbreak and indicated that response teams were being deployed to support DRC health authorities with case investigation, contact tracing, and infection prevention and control measures at affected health facilities. The organisation has also activated its regional emergency coordination mechanisms and is working to verify the geographic scope of transmission — a critical unknown that will determine whether a WHO Public Health Emergency of International Concern designation comes into play.
In the coming days, Nigerians and West African health officials should watch for three things: whether WHO confirms the outbreak zone overlaps with any active conflict displacement routes — which would dramatically accelerate spread across borders; whether any travel-associated cases surface in Kinshasa, from which multiple weekly flights depart to Lagos and Abuja; and whether the NCDC activates its Integrated Disease Surveillance and Response protocols at international airports, a step that proved decisive in 2014. A vaccine for Bundibugyo virus disease does not yet exist at scale, though candidate vaccines developed after the 2012 outbreak are in early-stage trials — meaning containment at source remains the only reliable firewall.
As the DRC races to contain a virus it has faced before, the rest of the continent is reminded once again that in a region where one outbreak in a forest clearing can reach an international airport within 48 hours, preparedness is not a health ministry budget line — it is the difference between an outbreak and a catastrophe.
